Abstract
ObjectivesTo describe the clinical presentation of MOG antibody disease (MOG-AD) in a series of patients at a single academic center. MethodsWe performed a retrospective review of patients with MOG antibodies. ResultsWe review the clinical presentation of 11 patients with MOG antibodies. In patients seen at Duke University Health System with MOG antibodies, the most common presentation was optic neuritis. Rituximab was the most used treatment for long-term management. ConclusionsOur case series highlights the common presentation of MOG antibody disease (MOG-AD) at a single academic medical center.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
